The Latest
-
Insulet reports 18 serious adverse events with recall of Omnipod 5 insulin pumps
The company is recalling certain lots of its insulin patch pumps after finding a small tear in the internal tubing may cause insulin to leak inside the pod.
-
Genetic tests come under scrutiny in Trump administration’s fraud crackdown
As the Centers for Medicare and Medicaid Services calls for public feedback on how to stop lab test fraud, experts say a tailored regulatory strategy will be key to avoid stifling innovation.
-
Stryker investigating cyberattack that caused widespread outage
The full scope of the impact, including operational and financial effects, is not yet known. Stryker does not have a timeline for full restoration of its systems.
Updated March 12, 2026 -
Advita Ortho receives warning letter related to shoulder system
Advita Ortho was formed after orthopedic implant maker Exactech sold its assets in bankruptcy.
-
Insulet posts clinical data on fully closed-loop insulin delivery system
The company aims to start a pivotal trial this year, file for 510(k) clearance in 2027 and launch the device in 2028.
-
Vitestro raises $70M to ready blood collection robot for US launch
The company is scaling up manufacturing and commercial activities as it prepares to enter the U.S. market via the Food and Drug Administration’s de novo pathway.
-
Medtronic elevates Sean Haag to president of ENT
Haag, who has worked at Medtronic for 20 years, will also serve on the leadership team for the neuroscience group.
-
Coloplast names former J&J executive Gavin Wood as CEO
Wood spent 20 years at J&J, culminating in a spell as company group chairman for the medtech business in Europe, the Middle East and Africa.
-
Medtronic to acquire Scientia Vascular for $550M
The Scientia deal follows Medtronic’s announcement in February that it’ll acquire CathWorks for up to $585 million.
-
SS Innovations raises $18.6M as surgical robot nears US market
Intuitive co-founder Fred Moll invested $2 million, supporting SS Innovations’ efforts to launch its robot in the U.S.
-
ARPA-H launches program to develop biosensors that can track multiple signals
The research initiative is part of a broader focus on wearables at the Department of Health and Human Services.
-
Agilent to buy Biocare Medical for $950M
Biocare’s strong growth in immunohistochemistry is expected to strengthen Agilent’s ability to develop new in vitro diagnostic antibodies.